Ligand profile
CHEMBL2178307
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL2178307- UniProt (similar protein)
P0AEK4- pchembl
- 6.640 (~229.1 nM)
- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.7
- −1 ≤ LogP ≤ 5 4.15
- MW ≤ 500 Da 258.3
- LogP ≤ 5 4.15
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 38.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCc1ccc(Oc2ccc(OC)cc2)c(O)c1CCCc1ccc(Oc2ccc(OC)cc2)c(O)c1
InChI=1S/C16H18O3/c1-3-4-12-5-10-16(15(17)11-12)19-14-8-6-13(18-2)7-9-14/h5-11,17H,3-4H2,1-2H3InChI=1S/C16H18O3/c1-3-4-12-5-10-16(15(17)11-12)19-14-8-6-13(18-2)7-9-14/h5-11,17H,3-4H2,1-2H3
OYJXBTQQZHDDTG-UHFFFAOYSA-NOYJXBTQQZHDDTG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL2178307 →
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL2178307”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 59
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).